Abstract
The prevalence of IgG antibodies reactive with Toxoplasma gondii in the female population of the County of Split Dalmatia was investigated by enzyme linked immunosorbent assay. Of a total of 1109 serum samples collected from female subjects, 423 (38.1%) reacted with T. gondii. The frequency of positive sera increased with age. Theoretical incidence of congenital toxoplasmosis was calculated from the annual increase in cumulative prevalence of antibodies between different age groups among the women of childbearing age. The estimated theoretical incidence of congenital toxoplasmosis was 1.4 per 100 pregnancies of adolescents (16–20 years) and decreased to 0.1% in seronegative pregnant women aged 41–45.
Similar content being viewed by others
References
Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 2nd edn. Philadelphia: WB Saunders Company, 1990; 89–195.
McCabe RE, Remington JS. Toxoplasma gondii. In: Mendell GL, Douglas RG Jr, Bennet JE (eds), Principles and Practice of Infectious Disease, 2nd edn. New York: Churchill Livingstone, 1990; 1540–1548.
Frenkel JK. Toxoplasmosis. Ped Clin North America 1985; 32: 917–932.
Luft BJ, Remington JS. Toxoplasmic encephalitis. J Infect Dis 1988; 157: 2–21.
Desmonts G, Courver J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med 1974; 290: 1110–1116.
Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of con-genital toxoplasmosis. Lancet 1985; 8620: 500–504.
Foulon W, Naessens A, Lauwers S, De Menter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 1988; 72: 363–366.
Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992; (Suppl 84): 32–37.
Hengst P. Screening for toxoplasmosis in pregnant women: Presentation of a screening program in the former “East”-Germany, and the present status in Germany. Scand J Infect Dis 1992; (Suppl 84): 38–42.
Thulliez P. Screening program for congenital toxoplasmosis in France. Scand J Infect Dis 1992; (Suppl 84): 43–45.
Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36: 2900–2906.
Logar J, Novak-Antolič Ž, Zore A. Serological screening for toxoplasmosis in pregnancy in Slovenia. Scand J Infect Dis 1995; 27: 163–164.
Ades AE, Nokes DJ. Modeling age-and time-specific incidence from seroprevalence: Toxoplasmosis. Am J Epidemiol 1993; 137: 1022–1034.
Ljungström I, Gille E, Nokes J, Linder E, Forsgren M. Seroepidemiology of Toxoplasma gondii among preg-nant women in different parts of Sweden. Eur J Epidemiol 1995; 11: 149–156.
Prebeg Ž, Babič A, Bezjak Lj, et al. Dob menarhe učenica u Hrvatskoj. Lijč Vjesn 1979; 101: 477–479.
Valcalvi PP, Natali A, Soliani L, Montali S, Dettori G, Cheezi C. Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). Eur J Epidemiol 1995; 11: 333–337.
Joynson DHM. Epidemiology of toxoplasmosis in the UK. Scand J Infect Dis 1992; Suppl 84: 65–69.
Ahlfors K, Börjeson M, Huldt G, Forsberg E. Incidence of toxoplasmosis in pregnant women in the city of Malmö, Sweden. Scand J Infect Dis 1989; 21: 315–321.
Lappalainen M, Koskela P, Hedman K, et al. Incidence of primary toxoplasma infections during pregnancy in southern Finland: A prospective cohort study. Scand J Infect Dis 1992; 24: 97–104.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Punda-Polić, V., Tonkić, M. & Čapkun, V. Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol 16, 875–877 (2000). https://doi.org/10.1023/A:1007606501923
Issue Date:
DOI: https://doi.org/10.1023/A:1007606501923